Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2010 Issue 15
Distribution of earthworm fibrinolytic enzyme in rat gastrointestinal tract after oral administration
WANG Xue-qing1;ZHANG Yuan1;PAN Rong2;3;HE Rong-qiao2
..............page:1360-1364
Sensitization study of traditional Chinese medicine injections with Tween 80 in the Beagle dogs
YAN Wei-juan1;2;LI Lian-da2;ZHANG Mei-yu2;LI Yi-kui2
..............page:1369-1371,1375
Development of nitrate NO-releasing agents
LUO Gang;CHEN Yu-ying
..............page:1322-1328
miao zhun he xin xiang wai you xu kuo zhan
ding shu juan ;
..............page:1289-1290
Extraction of anthraquinone derivatives from rhubarb via continuously biphasic hydrolysis
JIA Zhong1;MA Jian-jun1;DING Yan-hong2;HE Dian3;YANG Jian-yu3
..............page:1365-1368
New progresses in studies of safety pharmacology
CHE Ai-ping;WANG Jie;XIA Zhen-na;JIANG Hua;YUAN Bo-jun;LU Guo-cai
..............page:1309-1313
Application and management of ultra-fine powder (UFP) technology in traditional Chinese medicine
ZHENG Yong-hong1;LONG Ji-hong1;LI Feng2;ZHANG Ai-jun2
..............page:1296-1298,1308
xin xi
..............page:1364,1384
Pharmacology and clinical evaluation of iloperidone
WANG Zhi-hong;ZHENG Yu-jing
..............page:1293-1295,1328
Retrospective analysis of antibacterial drug used in our hospital during 2006-2008
HUANG Ji-xun;ZHAO Guang-yu
..............page:1380-1384
Correlation fingerprint of tea polyphenols intravenous injection by HPLC
YANG Mei-yan1;2;GAO Chun-sheng1;SHEN Bao-zhen3;LI Nan2
..............page:1376-1379
In vitro/vivo evaluation of drug release from carbon nanotube-isoliquiritigenin complex
MU Chun-hai;HAN Bo;LI Chao-peng;CHEN Wen;JIANG Fa-shou
..............page:1372-1375
Progress in thrombolytic drugs from microbial metabolites
LI Xiao-hua1;2;PANG Hui2
..............page:1329-1332
Mental disorders due to oseltamivir phosphate
LI Zheng;ZHANG Yu-feng;FU De-xing
..............page:1385-1386
Optimization of prasugrel synthesis
CHENG Xing-dong;TONG Ling;YANG Yu-lei;YUAN Zhe-dong
..............page:1314-1316
Current situation of anti-HIV agents from microorganisms
ZHOU Jun;ZHENG Heng;GU Jue-fen
..............page:1317-1321
WINDOW OF NEW DRUGS
..............page:1291-1292
Effect of penehyclidine on myocardial ischemia-reperfusion injury in patients undergoing valve replacement
LIU Liu;ZHOU Hai-yang;WANG Jian-bin;L Zhi-ping
..............page:1351-1354
A phase Ⅲ trial of compound Xiebai capsules in the treatment of acute exacerbation of chronic bronchitis
LIU Song-shan1;HE Cheng-shi1;YANG Ren-xu1;HU Si-yuan2;LIU Gui-ying2;ZHANG Rui-min3;MAO Bing3;XU Yan-ling4;CAI Hong-yan5;LIU Jian-qiu6;ZHU Qi-yong7
..............page:1333-1336,1354
A phase Ⅰ tolerance study of mouse nerve growth factor for injection
LI Jian-ming1;LI Guo-xin2;HU Hai-tang3;JIANG Chun-mei2;ZHAO Chun-yan2;LIU Xue-song2
..............page:1337-1341
Ethical review of adverse events in clinical research
WANG Xiu-qin;XIONG Ning-ning
..............page:1299-1301
Hypoglycemic effect of a new Exenatide analog in rats with type 2 diabetes mellitus
WANG Xue-yun;ZHANG Shuang;LI Hong;YANG Shi-jie
..............page:1347-1350
Monitoring and management of adverse events in phase I tolerance trials of new traditional Chinese medicines
LI Yan-fen;HUANG Yu-hong;SUN Jin-xia;WANG Bao-he
..............page:1302-1304